Literature DB >> 18059227

Non-neoplastic renal diseases are often unrecognized in adult tumor nephrectomy specimens: a review of 246 cases.

Kammi J Henriksen1, Shane M Meehan, Anthony Chang.   

Abstract

The pathologic evaluation of tumor nephrectomy specimens focuses on the diagnosis, grading, and staging of the neoplasm. The presence of coincidental non-neoplastic diseases in these specimens may have significant implications for patient outcomes. The purpose of this study is to determine the spectrum of non-neoplastic disease processes that may be overlooked in tumor nephrectomies, and to ascertain the extent to which surgical pathologists are trained to recognize these lesions. We reviewed the hematoxylin and eosin-stained slides of 246 adult tumor nephrectomy specimens with an emphasis on the non-neoplastic renal parenchyma. Further analysis of cases with pathologic alterations included special stains and direct immunofluorescence microscopy. The surgical pathology reports were reviewed to determine whether the non-neoplastic lesions were originally identified. We also surveyed United States pathology residency programs to determine how many require training in medical renal pathology. Forty-one cases (16.7%) had alterations, such as diffuse and/or nodular mesangial sclerosis, mesangial hypercellularity, or glomerular basement membrane thickening that warranted further study. After further work-up and clinical correlation, the pathologic changes in 24 cases were categorized as follows: diabetic nephropathy (19 cases) of which one demonstrated atheroembolic disease, thrombotic microangiopathy (3 cases), sickle cell nephropathy (1 case), and focal segmental glomerulosclerosis (1 case). Twenty-one (88%) of these diagnoses were not identified at initial pathologic evaluation. Only 35 of 98 pathology residency programs that responded to our survey require any formal training in medical renal pathology. Although accurate pathologic evaluation of renal neoplasms remains essential, surgical pathologists should be aware that coincidental non-neoplastic renal diseases are common, often not recognized, and may have important implications for patient care. Further consideration should be given to the training requirements of pathology residents and the guidelines for evaluation of nephrectomy specimens to avoid missing non-neoplastic renal lesions.

Entities:  

Mesh:

Year:  2007        PMID: 18059227     DOI: 10.1097/PAS.0b013e31804ca63e

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  24 in total

Review 1.  Evaluation and management of small renal masses: looking beyond the tumor margin.

Authors:  Michael Garcia-Roig; Michael A Gorin; Merce Jorda
Journal:  Curr Urol Rep       Date:  2012-02       Impact factor: 3.092

2.  Pathologic evaluation of non-neoplastic renal parenchyma in partial nephrectomy specimens.

Authors:  Michael Garcia-Roig; Michael A Gorin; Carlos Parra-Herran; Monica Garcia-Buitrago; Bruce R Kava; Merce Jorda; Mark S Soloway; Murugesan Manoharan; Gaetano Ciancio
Journal:  World J Urol       Date:  2011-06-21       Impact factor: 4.226

Review 3.  Risk of chronic kidney disease after cancer nephrectomy.

Authors:  Lin Li; Wei Ling Lau; Connie M Rhee; Kevin Harley; Csaba P Kovesdy; John J Sim; Steve Jacobsen; Anthony Chang; Jaime Landman; Kamyar Kalantar-Zadeh
Journal:  Nat Rev Nephrol       Date:  2014-01-14       Impact factor: 28.314

Review 4.  Noncardiac vascular toxicities of vascular endothelial growth factor inhibitors in advanced cancer: a review.

Authors:  Dorothy Keefe; Joanne Bowen; Rachel Gibson; Thean Tan; Meena Okera; Andrea Stringer
Journal:  Oncologist       Date:  2011-03-25

5.  Renal pathology in hematopoietic cell transplant recipients: a contemporary biopsy, nephrectomy, and autopsy series.

Authors:  Brian T Brinkerhoff; Donald C Houghton; Megan L Troxell
Journal:  Mod Pathol       Date:  2016-03-25       Impact factor: 7.842

Review 6.  The Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma.

Authors:  Susie L Hu; Anthony Chang; Mark A Perazella; Mark D Okusa; Edgar A Jaimes; Robert H Weiss
Journal:  J Am Soc Nephrol       Date:  2016-03-09       Impact factor: 10.121

7.  Larger Nephron Size and Nephrosclerosis Predict Progressive CKD and Mortality after Radical Nephrectomy for Tumor and Independent of Kidney Function.

Authors:  Aleksandar Denic; Hisham Elsherbiny; Aidan F Mullan; Bradley C Leibovich; R Houston Thompson; Luisa Ricaurte Archila; Ramya Narasimhan; Walter K Kremers; Mariam P Alexander; John C Lieske; Lilach O Lerman; Andrew D Rule
Journal:  J Am Soc Nephrol       Date:  2020-09-16       Impact factor: 10.121

8.  Renal histologic parameters influencing postoperative renal function in renal cell carcinoma patients.

Authors:  Myoung Ju Koh; Beom Jin Lim; Kyu Hun Choi; Yon Hee Kim; Hyeon Joo Jeong
Journal:  Korean J Pathol       Date:  2013-12-24

9.  Significance of the nonneoplastic renal parenchymal findings in robotic partial nephrectomy series.

Authors:  Ercan Malkoç; Matthew J Maurice; Oktay Akça; Önder Kara; Homayoun Zargar; Hiury Andrade; Daniel Ramirez; Peter Caputo; Robert Stein; Demirjian Sevag; Jihad H Kaouk
Journal:  J Nephrol       Date:  2018-02-16       Impact factor: 3.902

10.  Characterization of mild and severe post-radical nephrectomy renal functional deterioration utilizing histopathological evaluation of non-neoplastic nephrectomized renal parenchyma.

Authors:  Takehiro Sejima; Tetsuya Yumioka; Noriya Yamaguchi; Hideto Iwamoto; Toshihiko Masago; Shuichi Morizane; Masashi Honda; Atsushi Takenaka
Journal:  Int J Clin Oncol       Date:  2015-10-08       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.